The impact of JAK2V617F mutation on Philadelphia-negative myeloproliferative neoplasms.

Turk J Med Sci · 2022 · PMC10734827 · PMID 34482679

Europe PMC DOI

hedged sentence

0.0610

closest p · 1.2× alpha

0.0610

boldest claim

The sentences

showed a trendp = 0.061so close (0.05 < p ≤ 0.1)

JAK2V617F-negative ET patients showed a trend towards higher rate of leukemic transformation (p = 0.061).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.